Privia Health Files Routine 8-K for Regulation FD Disclosure

TL;DR

**Privia Health filed a routine 8-K, no major news here.**

AI Summary

Privia Health Group, Inc. (PRVA) filed an 8-K on January 8, 2024, to disclose information under Regulation FD and to include financial statements and exhibits. This filing is a routine disclosure, indicating no major new events but rather a formal update on previously shared information or minor operational details. For investors, this means there are no immediate red flags or significant positive catalysts revealed in this specific filing, suggesting a neutral impact on the stock unless the undisclosed Regulation FD information contains material news.

Why It Matters

This filing is a standard procedural update, indicating that Privia Health Group is complying with SEC regulations by formally disclosing information that may have been shared previously or is not considered a major event.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure for Regulation FD and exhibits, which typically does not introduce new risks.

Analyst Insight

Given this is a routine compliance filing without specific material news, a smart investor would monitor subsequent filings or news releases for the actual content of the Regulation FD disclosure or any significant financial updates, as this 8-K itself provides no actionable information.

Key Numbers

• 001-40365 — Commission File No. (SEC identification number for Privia Health Group, Inc.)
• 81-3599420 — I.R.S. Employer Identification No. (IRS identification number for Privia Health Group, Inc.)
• 571-366-8850 — Registrant's telephone number (contact number for Privia Health Group, Inc.)

Key Players & Entities

• Privia Health Group, Inc. (company) — the registrant filing the 8-K
• PRVA (company) — the trading symbol for Privia Health Group, Inc.
• The Nasdaq Global Select Market (company) — the exchange where Privia Health Group's common stock is registered
• January 8, 2024 (date) — the date of the earliest event reported and filing date
• $0.01 (dollar_amount) — par value per share of common stock

FAQ

From the Filing

0001759655-24-000004.txt : 20240108 0001759655-24-000004.hdr.sgml : 20240108 20240108080131 ACCESSION NUMBER: 0001759655-24-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 34 CONFORMED PERIOD OF REPORT: 20240108 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 24518407 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20240108.htm 8-K prva-20240108 0001759655 FALSE 0001759655 2024-01-08 2024-01-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure. We are furnishing this Current Report on Form 8-K to furnish materials that will be provided at meetings with institutional investors or analysts. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com . This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means. The information in this Current Report on Form 8-K (including the exhibit) is furnishe